welcome
CNBC

CNBC

Health

Health

Drugmakers bet billions that targeted radiation could become the next cancer breakthrough

CNBC
Summary
Nutrition label

76% Informative

Radiopharmaceuticals are currently available for some neuroendocrine tumors and prostate cancer.

They could one day be used for numerous cancers.

Drugmakers are betting that delivering radiation directly to tumors will become the next big cancer breakthrough.

Bristol Myers Squibb , AstraZeneca , Eli Lilly and other pharmaceutical companies have spent some $10 billion on deals.

Radiopharmaceuticals start decaying once they're made, so they're only good for a few days .

It could take years to understand the true potential of the technology, as many experimental drugs are still in the early phases of development.

Large pharmaceutical companies aren't waiting to jump into the race.

VR Score

84

Informative language

88

Neutral language

62

Article tone

informal

Language

English

Language complexity

57

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links